Batch number
Also known as: lot number, batch ID, production lot, manufacturing batch
Definition
A batch number (also called a lot number) is a unique code assigned to each batch or production run of a pharmaceutical, chemical, or biological product. The batch number serves multiple critical functions: it links a finished product to specific manufacturing and testing records, enabling traceability if quality issues or safety concerns arise; it allows identification of products from the same production run if a recall or investigation becomes necessary; and it facilitates inventory management and expiration dating. Each batch is independently manufactured under specified conditions and tested to verify that it meets quality standards. When a quality issue is discovered—such as contamination or potency deviation—the batch number allows investigators to identify which production run is affected and whether other batches are similarly affected. For research applications, the batch number should be recorded in study documentation so that if unexpected results occur, researchers can determine whether a quality issue with a specific batch contributed to the findings.
Batch-specific quality data is documented in Certificates of Analysis, which are typically identified by batch number. This allows researchers to verify that the specific batch they are using has been tested and meets specifications. If multiple batches of the same peptide are used across different parts of a study, batch-specific quality data becomes important for troubleshooting if results vary between batches. Some variation between batches is expected (within specification), but unusually large variation might indicate a manufacturing or testing issue.
For long-term studies or studies using large quantities of peptide, batch consistency is important. Researchers should examine quality data for multiple batches before commencing studies to understand expected batch-to-batch variation and to establish a baseline for recognizing genuinely unusual variation. In regulatory submissions for new drugs, batch-related data (including analytical results from multiple batches, stability data, and comparative bioavailability across batches) is required to demonstrate consistent manufacturing.